Although LDH is a negative prognostic factor in melanoma, patients who receive checkpoint inhibitors may still have responses of long duration even when their LDH level is high.

Dr Alan Jacobs reports on the first functional evidence of gene variants with implications for the pathology of ADHD

Over 3000 patients have responded to an online request from Boston researchers to contribute tumor tissue and saliva for the purpose of accelerating research on metastatic breast cancer.

Dr Maurie Markman explains that sharing genetic data with study participants encourages greater clinical trial involvement.

Dr Chodak reviews a new algorithm intended to simplify PSA testing. But is it ready for prime time?

Use of molecular diagnostics in cancer can be tricky, but Dr Lundberg says the pathologist can ask important questions to help guide the process.

Jessica Richman, CEO of uBiome, talks about her passion for citizen science, her interest in the microbiome, and how uBiome aims to serve public health.

Dr Jeffrey Weber, Medscape's new commentator on melanoma and immunotherapy, discusses impressive data on overall survival and combination therapy presented at AACR 2016.

By leading an unprecedented group of companies, institutions, and scientists in Cancer Moonshot 2020, Patrick Soon-Shiong has set out to change cancer care forever. Here's how he plans to do it.

Prospective screening for a genetic variant of DPD, an enzyme that catabolizes 5-FU, reduces mortality from 10% to 0% in patients with this variant and is cost-effective. Dr David Kerr is all for it.